Chinese start-up SMEAL Shanghai Biotechnology is competing for a slice of China’s diet replacement and weight control market by selling its products in an atypical format – by packaging powdered beverage in bottles instead of sachets or tins.
Supplements containing cannabidiol (CBD) and functional foods with hemp are among the biggest buzz categories in nutrition right now, but can they become mainstream commercial success stories in APAC?
Early studies on animals have linked consumption of polyphenol-rich berries to improvements in some cognitive markers. This has warranted studies on humans, and results are shedding more light on how berries may benefit our brain health.
Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
Asia-Pacific's growing ageing population has led to increased innovation in the bone and joint health supplement space, but products targeting more life stages and categories are also finding success in the sector.
French company Robertet is bringing its health and beauty businesses into China, after it first established its flavours and fragrances business in the country 10 years ago.
Glanbia Nutritionals is seeking to propel its growth in China via general lifestyle nutrition, in addition to its sports nutrition stronghold, with a key focus on creating new concepts in tandem with its customers.
Australian social influencer-backed health and wellness company Keep It Cleaner is banking on minimalist ingredients and multi-faceted expansion to break into the Asian market.
Taiwanese firm Chambio is eyeing the oral care, weight management, and immune health markets in China with heat-killed postbiotics, the metabolic by-product of probiotics.
Standardization in herbal products will boost consumer acceptance and market uptake, says Sabinsa president Shaheen Majeed, using the company’s Shagandha ashwaganda ingredient as an example.
Australian firms Entity Health and Pharmako Biotechnologies have identified the key factors supplement firms should consider when investing in delivery system innovation in APAC.
